Reti on Blast Oma
-
Upload
nnmmbbvvccxxzz -
Category
Documents
-
view
224 -
download
0
Transcript of Reti on Blast Oma
![Page 1: Reti on Blast Oma](https://reader035.fdocuments.us/reader035/viewer/2022062401/577ce3e01a28abf1038d435b/html5/thumbnails/1.jpg)
7/30/2019 Reti on Blast Oma
http://slidepdf.com/reader/full/reti-on-blast-oma 1/40
Grand RoundsTerry J. Alexandrou, MD
Department of Ophthalmology and Visual ScienceThe University of Chicago
1/4/2006
![Page 2: Reti on Blast Oma](https://reader035.fdocuments.us/reader035/viewer/2022062401/577ce3e01a28abf1038d435b/html5/thumbnails/2.jpg)
7/30/2019 Reti on Blast Oma
http://slidepdf.com/reader/full/reti-on-blast-oma 2/40
HPI – Patient T.F.
12/12/2005
16 month old A.A. male presents with a 1 monthhistory of “a left white pupil” and “left eyeturning outwards”, according to mom.
![Page 3: Reti on Blast Oma](https://reader035.fdocuments.us/reader035/viewer/2022062401/577ce3e01a28abf1038d435b/html5/thumbnails/3.jpg)
7/30/2019 Reti on Blast Oma
http://slidepdf.com/reader/full/reti-on-blast-oma 3/40
PMH
• None
• Full term – uncomplicated delivery
![Page 4: Reti on Blast Oma](https://reader035.fdocuments.us/reader035/viewer/2022062401/577ce3e01a28abf1038d435b/html5/thumbnails/4.jpg)
7/30/2019 Reti on Blast Oma
http://slidepdf.com/reader/full/reti-on-blast-oma 4/40
Meds and Allergies
• Medications: None
• Allergies: NKDA
![Page 5: Reti on Blast Oma](https://reader035.fdocuments.us/reader035/viewer/2022062401/577ce3e01a28abf1038d435b/html5/thumbnails/5.jpg)
7/30/2019 Reti on Blast Oma
http://slidepdf.com/reader/full/reti-on-blast-oma 5/40
Family History
None
Has a non-identical twin.
![Page 6: Reti on Blast Oma](https://reader035.fdocuments.us/reader035/viewer/2022062401/577ce3e01a28abf1038d435b/html5/thumbnails/6.jpg)
7/30/2019 Reti on Blast Oma
http://slidepdf.com/reader/full/reti-on-blast-oma 6/40
![Page 7: Reti on Blast Oma](https://reader035.fdocuments.us/reader035/viewer/2022062401/577ce3e01a28abf1038d435b/html5/thumbnails/7.jpg)
7/30/2019 Reti on Blast Oma
http://slidepdf.com/reader/full/reti-on-blast-oma 7/40
Always Listen to Mom!!!
![Page 8: Reti on Blast Oma](https://reader035.fdocuments.us/reader035/viewer/2022062401/577ce3e01a28abf1038d435b/html5/thumbnails/8.jpg)
7/30/2019 Reti on Blast Oma
http://slidepdf.com/reader/full/reti-on-blast-oma 8/40
EXAM Visual acuity:
OD – Fix and FollowOS – Unable to fix or follow; Pt. becomes agitated with
occlusion of the right eyePupils: +LAPD
Variable Exotropia – 30-40 prism diopters
Anterior Exam:- Cornea, AC, iris, lens normal OU
Fundus Exam:- Difficult, however able to see a moderately large whitemass in the left eye. Right eye appears normal.
![Page 9: Reti on Blast Oma](https://reader035.fdocuments.us/reader035/viewer/2022062401/577ce3e01a28abf1038d435b/html5/thumbnails/9.jpg)
7/30/2019 Reti on Blast Oma
http://slidepdf.com/reader/full/reti-on-blast-oma 9/40
• How would you pursue a diagnosis?
![Page 10: Reti on Blast Oma](https://reader035.fdocuments.us/reader035/viewer/2022062401/577ce3e01a28abf1038d435b/html5/thumbnails/10.jpg)
7/30/2019 Reti on Blast Oma
http://slidepdf.com/reader/full/reti-on-blast-oma 10/40
Superior Cut
![Page 11: Reti on Blast Oma](https://reader035.fdocuments.us/reader035/viewer/2022062401/577ce3e01a28abf1038d435b/html5/thumbnails/11.jpg)
7/30/2019 Reti on Blast Oma
http://slidepdf.com/reader/full/reti-on-blast-oma 11/40
Inferior Cuts
![Page 12: Reti on Blast Oma](https://reader035.fdocuments.us/reader035/viewer/2022062401/577ce3e01a28abf1038d435b/html5/thumbnails/12.jpg)
7/30/2019 Reti on Blast Oma
http://slidepdf.com/reader/full/reti-on-blast-oma 12/40
Exam Under Anesthesia
![Page 13: Reti on Blast Oma](https://reader035.fdocuments.us/reader035/viewer/2022062401/577ce3e01a28abf1038d435b/html5/thumbnails/13.jpg)
7/30/2019 Reti on Blast Oma
http://slidepdf.com/reader/full/reti-on-blast-oma 13/40
Left Eye
![Page 14: Reti on Blast Oma](https://reader035.fdocuments.us/reader035/viewer/2022062401/577ce3e01a28abf1038d435b/html5/thumbnails/14.jpg)
7/30/2019 Reti on Blast Oma
http://slidepdf.com/reader/full/reti-on-blast-oma 14/40
Left Eye
![Page 15: Reti on Blast Oma](https://reader035.fdocuments.us/reader035/viewer/2022062401/577ce3e01a28abf1038d435b/html5/thumbnails/15.jpg)
7/30/2019 Reti on Blast Oma
http://slidepdf.com/reader/full/reti-on-blast-oma 15/40
Left Eye
![Page 16: Reti on Blast Oma](https://reader035.fdocuments.us/reader035/viewer/2022062401/577ce3e01a28abf1038d435b/html5/thumbnails/16.jpg)
7/30/2019 Reti on Blast Oma
http://slidepdf.com/reader/full/reti-on-blast-oma 16/40
Differential?
![Page 17: Reti on Blast Oma](https://reader035.fdocuments.us/reader035/viewer/2022062401/577ce3e01a28abf1038d435b/html5/thumbnails/17.jpg)
7/30/2019 Reti on Blast Oma
http://slidepdf.com/reader/full/reti-on-blast-oma 17/40
Retinoblastoma
Coat’s Disease Ocular toxocariasisRetinal Astrocytic HamartomaPersistent Hyperplastic Primary Vitreous (PHPV)Retinopathy of Prematurity
![Page 18: Reti on Blast Oma](https://reader035.fdocuments.us/reader035/viewer/2022062401/577ce3e01a28abf1038d435b/html5/thumbnails/18.jpg)
7/30/2019 Reti on Blast Oma
http://slidepdf.com/reader/full/reti-on-blast-oma 18/40
Retinoblastoma
Epidemiology
Most common intraocular malignancy in children
1/15,000-1/20,000 live births
~300 new cases annually in the United States
No racial predilection
Occurs equally in males and females
![Page 19: Reti on Blast Oma](https://reader035.fdocuments.us/reader035/viewer/2022062401/577ce3e01a28abf1038d435b/html5/thumbnails/19.jpg)
7/30/2019 Reti on Blast Oma
http://slidepdf.com/reader/full/reti-on-blast-oma 19/40
Genetics – The Retinoblastoma Gene
Tumor Suppressor Gene
Chromosome 13 q 14
Knudson’s “Two -Hit” Hypothesis – recessive at a cellularlevel
Autosomal Dominant Inheritance
![Page 20: Reti on Blast Oma](https://reader035.fdocuments.us/reader035/viewer/2022062401/577ce3e01a28abf1038d435b/html5/thumbnails/20.jpg)
7/30/2019 Reti on Blast Oma
http://slidepdf.com/reader/full/reti-on-blast-oma 20/40
Genetics
Non – Heritable Form (60%)- Average age at Diagnosis is 24 months- Normal Life expectancy if cured of the eye tumor- Unilateral- Risk of additional cancers same as general population
Sporadic (93%) is not equivalent to Non-Heritable
![Page 21: Reti on Blast Oma](https://reader035.fdocuments.us/reader035/viewer/2022062401/577ce3e01a28abf1038d435b/html5/thumbnails/21.jpg)
7/30/2019 Reti on Blast Oma
http://slidepdf.com/reader/full/reti-on-blast-oma 21/40
Genetics
Heritable Form (40%)- Family History in 7-10%- New Germline Mutation in 30%- Average age at diagnosis is newborn to 12 months
- Multiple, bilateral tumors in 85 %- Predisposed to various cancers throughout life
- midline intracranial tumor (pineal and suprasellar region)-osteosarcomas and soft tissue sarcomas (teenage)
- melanomas and brain tumors (middle age)- lung and bladder cancer (later life)
![Page 22: Reti on Blast Oma](https://reader035.fdocuments.us/reader035/viewer/2022062401/577ce3e01a28abf1038d435b/html5/thumbnails/22.jpg)
7/30/2019 Reti on Blast Oma
http://slidepdf.com/reader/full/reti-on-blast-oma 22/40
Clinical Presentation
Leukocoria (54-62%)Strabismus (18-22%)
Red eye
Excessive TearingCorneal clouding (2/2 elevatedIOP)
HypopyonDiscoloration of the iris (2/2
neovascularization)ProptosisSpontaneous Globe perforation
“Cat’s Eye” appearance
![Page 23: Reti on Blast Oma](https://reader035.fdocuments.us/reader035/viewer/2022062401/577ce3e01a28abf1038d435b/html5/thumbnails/23.jpg)
7/30/2019 Reti on Blast Oma
http://slidepdf.com/reader/full/reti-on-blast-oma 23/40
Diagnosis
Complete general historyExam under anesthesiaUltrasongraphyCTMRI
![Page 24: Reti on Blast Oma](https://reader035.fdocuments.us/reader035/viewer/2022062401/577ce3e01a28abf1038d435b/html5/thumbnails/24.jpg)
7/30/2019 Reti on Blast Oma
http://slidepdf.com/reader/full/reti-on-blast-oma 24/40
Treatment Options
EnucleationChemoreduction with Local tumor ablationCryotherapy
External-Beam Radiation TherapyBrachytherapy
Treatment options in T.F.?
![Page 25: Reti on Blast Oma](https://reader035.fdocuments.us/reader035/viewer/2022062401/577ce3e01a28abf1038d435b/html5/thumbnails/25.jpg)
7/30/2019 Reti on Blast Oma
http://slidepdf.com/reader/full/reti-on-blast-oma 25/40
International Classification for Intraocular Retinoblastoma
A) Group A (Very Low Risk) - Small discrete intraretinal tumors away from the foveola and disc
- All tumors are 3 mm or smaller in greatest dimension, confined to the retina and - All tumors are located further than 3 mm from the foveola and 1.5 mm from the optic disc
B) Group B (Low Risk) - All remaining discrete retinal tumors without seeding - All tumors confined to the retina not in group A - Any tumor size and location with no vitreous or subretinal seeding
C) Group C (Moderate Risk) - Discrete local disease with minimal focal subretinal or vitreous seeding
-Tumor(s) must be discrete- Subretinal fluid, present or past, without gross seeding, involving up to one quadrant of retina- Local subretinal seeding, present or past, less than 5 mm from the tumor- Focal fine vitreous seeding close to discrete tumor
D) Group D (High Risk) - Diffuse disease with significant vitreous and/or subretinal seeding
- Tumor(s) may be massive or diffuse- Subretinal fluid, present or past up to total retinal detachment- Diffuse subretinal seeding, may include subretinal plaques or tumor nodules- Diffuse or massive vitreous disease may include "greasy" seeds or avascular tumor masses
E) Group E (Very High Risk)
![Page 26: Reti on Blast Oma](https://reader035.fdocuments.us/reader035/viewer/2022062401/577ce3e01a28abf1038d435b/html5/thumbnails/26.jpg)
7/30/2019 Reti on Blast Oma
http://slidepdf.com/reader/full/reti-on-blast-oma 26/40
Enucleation
![Page 27: Reti on Blast Oma](https://reader035.fdocuments.us/reader035/viewer/2022062401/577ce3e01a28abf1038d435b/html5/thumbnails/27.jpg)
7/30/2019 Reti on Blast Oma
http://slidepdf.com/reader/full/reti-on-blast-oma 27/40
Path – Gross Specimen
![Page 28: Reti on Blast Oma](https://reader035.fdocuments.us/reader035/viewer/2022062401/577ce3e01a28abf1038d435b/html5/thumbnails/28.jpg)
7/30/2019 Reti on Blast Oma
http://slidepdf.com/reader/full/reti-on-blast-oma 28/40
Path - Micro
Not ready as of 1/3/06
![Page 29: Reti on Blast Oma](https://reader035.fdocuments.us/reader035/viewer/2022062401/577ce3e01a28abf1038d435b/html5/thumbnails/29.jpg)
7/30/2019 Reti on Blast Oma
http://slidepdf.com/reader/full/reti-on-blast-oma 29/40
Is Enucleation enough? Are there any indications for adjuvant
chemotherapy in this patient?
What pathologic features are risk factors formetastatic disease in the future?
![Page 30: Reti on Blast Oma](https://reader035.fdocuments.us/reader035/viewer/2022062401/577ce3e01a28abf1038d435b/html5/thumbnails/30.jpg)
7/30/2019 Reti on Blast Oma
http://slidepdf.com/reader/full/reti-on-blast-oma 30/40
Pathologic features implicated in the past
Involvement of:- Choroid - controversial
- Optic nerve – posterior to lamina cribosa- residual tumor in optic nerve stump
- Sclera
- Anterior Chamber
![Page 31: Reti on Blast Oma](https://reader035.fdocuments.us/reader035/viewer/2022062401/577ce3e01a28abf1038d435b/html5/thumbnails/31.jpg)
7/30/2019 Reti on Blast Oma
http://slidepdf.com/reader/full/reti-on-blast-oma 31/40
CHILDREN’S ONCOLOGY GROUP
“A Study of Unilateral Retinoblastoma With and Without Histopathologic High-Risk Features
and the Role of Adjuvant Chemotherapy”
![Page 32: Reti on Blast Oma](https://reader035.fdocuments.us/reader035/viewer/2022062401/577ce3e01a28abf1038d435b/html5/thumbnails/32.jpg)
7/30/2019 Reti on Blast Oma
http://slidepdf.com/reader/full/reti-on-blast-oma 32/40
Study Chair: Murali Chintagumpala, MD (Baylor)Study Members :
Joan O’ Brien, MD (Ophthalmology, UCSF) Julie Stoner, Ph.D (Biostatistics, Nebraska)Katherine K. Matthay, MD (Hematology/Oncology, UCSF)
Anna T. Meadows, MD (Oncology, Children’s Hospital of Philadelphia) Ann M. Leahey, MD (Oncology, Children’s Hospital of Philadelphia) Arupa Ganguly, Ph.D (Human Genetics, Penn)Robert Zimmerman, MD (Neuro-Radiology, Philadelphia)Mary Herdy, CCRP (Michigan State University)Marcus H. Pettigrew (Research Coordinator, COG)
Study Pathologists :Daniel Albert, MD (Wisconsin)Ralph Eagle, MD (Wills)Patricia Chevez-Barrios, MD (The Methodist Hospital)
![Page 33: Reti on Blast Oma](https://reader035.fdocuments.us/reader035/viewer/2022062401/577ce3e01a28abf1038d435b/html5/thumbnails/33.jpg)
7/30/2019 Reti on Blast Oma
http://slidepdf.com/reader/full/reti-on-blast-oma 33/40
GOALS AND OBJECTIVES
1) Prospectively determine the prevalence of high-risk histopathologic features.
2) Demonstrate that patients without certain high-risk features canbe successfully treated with enucleation alone.
3) Estimate the event-free survival and overall survival in patientswith certain high-risk features who are treated with adjuvantchemotherapy.
4) Estimate the incidence of toxicities associated with the proposedadjuvant chemotherapy.
![Page 34: Reti on Blast Oma](https://reader035.fdocuments.us/reader035/viewer/2022062401/577ce3e01a28abf1038d435b/html5/thumbnails/34.jpg)
7/30/2019 Reti on Blast Oma
http://slidepdf.com/reader/full/reti-on-blast-oma 34/40
Eligibility Criteria
• Age: 0 to 6 years
• Diagnosis: All newly diagnosed children with Unilateral Retinoblastoma whoundergo enucleation as initial therapy
• Performance Level: Lansky score > 50
• Prior Therapy: No prior therapy other than enucleation
• Baseline MRI of the brain
• Organ Function Requirements: For patients with high-risk features who areto receive chemotherapy
![Page 35: Reti on Blast Oma](https://reader035.fdocuments.us/reader035/viewer/2022062401/577ce3e01a28abf1038d435b/html5/thumbnails/35.jpg)
7/30/2019 Reti on Blast Oma
http://slidepdf.com/reader/full/reti-on-blast-oma 35/40
Unilateral Disease
High-Risk Histopathologic
Features for which Adjuvant Therapy
is Indicated
No High-Risk
HistopathologicFeatures for which Adjuvant Therapy
is indicated
NoMetastatic
Disease
6 cycles of Chemotherapy Observation
MetastaticDisease
NoMetastatic
Disease
Follow-up Off Protocol Therapy
May enter other protocolsFollow-up
![Page 36: Reti on Blast Oma](https://reader035.fdocuments.us/reader035/viewer/2022062401/577ce3e01a28abf1038d435b/html5/thumbnails/36.jpg)
7/30/2019 Reti on Blast Oma
http://slidepdf.com/reader/full/reti-on-blast-oma 36/40
High-Risk Histopathologic Features
a) Posterior Uveal Invasion (includes choroidal invasion)
b) Any degree of concomitant choroid and optic n. involvement
c) Tumor involving the optic n. posterior to the lamina cribosa as anindependent finding
d) Scleral invasion
e) Anterior Chamber seeding
f) Ciliary body infiltration
g) Iris infiltration
![Page 37: Reti on Blast Oma](https://reader035.fdocuments.us/reader035/viewer/2022062401/577ce3e01a28abf1038d435b/html5/thumbnails/37.jpg)
7/30/2019 Reti on Blast Oma
http://slidepdf.com/reader/full/reti-on-blast-oma 37/40
High-Risk Histopathologic Features for which Adjuvant Therapy is Indicated
a) Massive choroid replacement (Posterior Uveal invasion grades IIC andIID)
b) Any posterior uveal involvement with any optic nerve involvementc) Optic nerve involvement posterior to the lamina cribosa
Posterior Uveal InvolvementI: Posterior uveal invasion absentII: Posterior uveal invasion present
IIA: largest dimension of tumor on slide < 1 mmIIB: largest dimension between 1-3 mmIIC: largest dimension > 3 mmIID: posterior uveal tumor noted grossly
![Page 38: Reti on Blast Oma](https://reader035.fdocuments.us/reader035/viewer/2022062401/577ce3e01a28abf1038d435b/html5/thumbnails/38.jpg)
7/30/2019 Reti on Blast Oma
http://slidepdf.com/reader/full/reti-on-blast-oma 38/40
Treatment Plan
• Treatment to start within 4 weeks of enucleation
• Consists of 6 cycles of Carboplantin, Etoposide and Vincristine givenevery 4 weeks
• Long term follow-up of patients
![Page 39: Reti on Blast Oma](https://reader035.fdocuments.us/reader035/viewer/2022062401/577ce3e01a28abf1038d435b/html5/thumbnails/39.jpg)
7/30/2019 Reti on Blast Oma
http://slidepdf.com/reader/full/reti-on-blast-oma 39/40
Financial considerations
12/12/05- New Ophth Patient $187.00
12/13/05- CT under anesthesia $3,112
12/15/05- Exam under anesthesia $9,075
12/21/05
- Enucleation $16,259
No payments received yet.
![Page 40: Reti on Blast Oma](https://reader035.fdocuments.us/reader035/viewer/2022062401/577ce3e01a28abf1038d435b/html5/thumbnails/40.jpg)
7/30/2019 Reti on Blast Oma
http://slidepdf.com/reader/full/reti-on-blast-oma 40/40
Practice based learning
1) Complete exam should be performed on parentsand siblings of retinoblastoma patients
2) Always listen to the parents – we have the
patients in our office for 30 minutes
Systems based Learning
1) Coordinate efforts between different specialties